News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,923 Results
Type
Article (86518)
Company Profile (656)
Press Release (759749)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232692)
Career Advice (4128)
Deals (39721)
Drug Delivery (129)
Drug Development (90985)
Employer Resources (198)
FDA (18112)
Job Trends (17341)
News (396483)
Policy (39754)
Tag
Academia (2999)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56842)
ALS (106)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (162)
Approvals (18070)
Artificial intelligence (315)
Autoimmune disease (29)
Automation (17)
Bankruptcy (405)
Best Places to Work (12631)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (448)
Bladder cancer (86)
Brain cancer (31)
Breast cancer (312)
Cancer (2487)
Cardiovascular disease (209)
Career advice (3535)
Career pathing (34)
CAR-T (178)
Cell therapy (495)
Cervical cancer (21)
Clinical research (73477)
Collaboration (937)
Company closure (2)
Compensation (586)
Complete response letters (30)
COVID-19 (2866)
CRISPR (50)
C-suite (276)
Cystic fibrosis (110)
Data (2384)
Decentralized trials (2)
Denatured (46)
Depression (55)
Diabetes (299)
Diagnostics (6923)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (133)
Drug pricing (132)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (97061)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130269)
Executive appointments (792)
FDA (19552)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (825)
Gene editing (124)
Generative AI (28)
Gene therapy (369)
GLP-1 (862)
Government (5175)
Grass and pollen (6)
Guidances (158)
Healthcare (20884)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (155)
Indications (30)
Infectious disease (3030)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (103)
Interviews (813)
IPO (17833)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (567)
Leadership (24)
Legal (10115)
Liver cancer (82)
Lung cancer (349)
Lymphoma (162)
Machine learning (9)
Management (65)
Manufacturing (369)
MASH (85)
Medical device (14630)
Medtech (14635)
Mergers & acquisitions (22453)
Metabolic disorders (807)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (119)
Neuropsychiatric disorders (34)
Neuroscience (2127)
NextGen: Class of 2025 (7667)
Non-profit (5081)
Now hiring (41)
Obesity (431)
Opinion (276)
Ovarian cancer (84)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (164)
Partnered (24)
Patents (260)
Patient recruitment (119)
Peanut (51)
People (65336)
Pharmaceutical (137)
Pharmacy benefit managers (22)
Phase I (22681)
Phase II (31913)
Phase III (24036)
Pipeline (1419)
Policy (180)
Postmarket research (3552)
Preclinical (10236)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (439)
Real estate (7392)
Recruiting (75)
Regulatory (26836)
Reports (58)
Research institute (2654)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (5)
RSV (49)
Schizophrenia (83)
Series A (143)
Series B (94)
Service/supplier (28)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (57)
The Weekly (83)
Vaccines (821)
Venture capitalists (45)
Weight loss (305)
Women's health (41)
Worklife (20)
Date
Today (186)
Last 7 days (1024)
Last 30 days (3300)
Last 365 days (35031)
2025 (12742)
2024 (37859)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (61)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (50167)
Australia (8836)
California (6711)
Canada (2109)
China (580)
Colorado (290)
Connecticut (307)
Delaware (169)
Europe (115129)
Florida (985)
Georgia (229)
Hawaii (1)
Idaho (64)
Illinois (636)
India (30)
Indiana (346)
Iowa (12)
Japan (178)
Kansas (113)
Kentucky (28)
Louisiana (14)
Maine (71)
Maryland (996)
Massachusetts (5140)
Michigan (252)
Minnesota (434)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (70)
New Hampshire (69)
New Jersey (1881)
New Mexico (30)
New York (1881)
North Carolina (1148)
North Dakota (9)
Northern California (2897)
Ohio (226)
Oklahoma (15)
Oregon (46)
Pennsylvania (1470)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (25)
South Dakota (1)
Southern California (2489)
Tennessee (108)
Texas (998)
United States (25602)
Utah (199)
Virginia (174)
Washington D.C. (72)
Washington State (615)
West Virginia (3)
Wisconsin (70)
846,923 Results for "karo pharma formerly known as karo bio ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 7 May 2025
May 8, 2025
·
5 min read
Press Releases
Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting
May 12, 2025
·
3 min read
Press Releases
Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)
May 7, 2025
·
4 min read
Press Releases
Notice to Annual General Meeting in AlzeCure Pharma AB
April 9, 2025
·
9 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
Press Releases
Circle Pharma to Present Late-Breaking Data at AACR 2025 Demonstrating Mechanism of Action for Novel Cyclin A/B RxL Inhibitors
April 22, 2025
·
2 min read
Press Releases
Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108
April 10, 2025
·
6 min read
Press Releases
Nemysis Limited Announces Collaboration With Avia Pharma AB as IHAT Distributor in Nordic Region
March 14, 2025
·
2 min read
Press Releases
Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
March 25, 2025
·
4 min read
1 of 84,693
Next
